Postma, N S <br/><br/>
Treatment with recombinant human tumour necrosis factor-alpha reduces parasitaemia and prevents Plasmodium berghei K173-induced experimental cerebral malaria in mice.  [electronic resource] 

 -  Parasitology  Jan 1999 
 - 7-15 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0031-1820 
<br/><br/><label>Standard No.: </label>10.1017/s0031182098003552  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Cutaneous<br/>Animals<br/>Antigens, CD--blood<br/>Drug Carriers<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Humans<br/>Infusion Pumps<br/>Liposomes<br/>Malaria, Cerebral--parasitology<br/>Mice<br/>Mice, Inbred C57BL<br/>Parasitemia--drug therapy<br/>Plasmodium berghei<br/>Receptors, Tumor Necrosis Factor--blood<br/>Receptors, Tumor Necrosis Factor, Type II<br/>Recombinant Proteins--therapeutic use<br/>Specific Pathogen-Free Organisms<br/>Time Factors<br/>Tumor Necrosis Factor-alpha--therapeutic use